Merck & Co

News

Merck's challenge to Pfizer's Prevnar grows

Pfizer's longstanding dominance of the pneumococcal vaccines category could be threatened by Merck & Co, which has just reported new data on its V116 shot in older adu

News

Study backs earlier use of Keytruda in cervical cancer

A phase 3 trial of Merck & Co’s checkpoint inhibitor Keytruda could support the expansion of its use in cervical cancer to include newly-diagnosed patients with less s

News

Merck sues US govt over Inflation Reduction Act

Pharma industry anger at US legislation that gives Medicare the power to negotiate drug prices has spilled over into the courts.

News

ASCO: Moderna, Merck melanoma vaccine set for phase 3

Moderna’s move into personalised cancer therapy continues to proceed at a rapid pace, with Merck & Co-partnered melanoma vaccine mRNA-4157 heading for a pivotal phase

News

ASCO: Can Imfinzi bring immunotherapy to ovarian cancer?

While immunotherapy has transformed the treatment of many cancers, it has failed to make much of an impact in advanced ovarian cancer, and AstraZeneca is hoping to change

News

NHS will roll out ‘lifeline’ endometrial cancer regimen

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-ex

Merck's challenge to Pfizer's Prevnar grows

Study backs earlier use of Keytruda in cervical cancer

Merck sues US govt over Inflation Reduction Act

ASCO: Moderna, Merck melanoma vaccine set for phase 3

ASCO: Can Imfinzi bring immunotherapy to ovarian cancer?

NHS will roll out ‘lifeline’ endometrial cancer regimen

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Merck & Co

Editor's Picks